Napo Pharmaceuticals

market

Napo aims to serve a wide variety of patients with diarrhea caused by many different underlying conditions -- from irritable bowel syndrome to cholera.

Current remedies for these patients often lack efficacy, and many have significant side effects. We believe that crofelemer will be a more effective and safer treatment option for millions of patients who suffer from diarrhea.